Bruntsch U - Search Results

1

Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group.

Eskens FA, Greim GA, van Zuylen C, Wolff I, Denis LJ, Planting AS, Muskiet FA, Wanders J, Barbet NC, Choi L, Capdeville R, Verweij J, Hanauske AR, Bruntsch U. Eskens FA, et al. Among authors: bruntsch u. Clin Cancer Res. 2000 May;6(5):1736-43. Clin Cancer Res. 2000. PMID: 10815892 Clinical Trial.

2

Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials Group.

Verweij J, Wanders J, Nielsen AL, Pavlidis N, Calabresi F, ten Bokkel Huinink W, Bruntsch U, Piccart M, Franklin H, Kaye SB. Verweij J, et al. Among authors: bruntsch u. Ann Oncol. 1994 Apr;5(4):375-6. doi: 10.1093/oxfordjournals.annonc.a058847. Ann Oncol. 1994. PMID: 8075039 Free article. Clinical Trial.

3

Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days.

Wolff I, Bench K, Beijnen JH, Bruntsch U, Cavalli F, de Jong J, Groot Y, van Tellingen O, Wanders J, Sessa C. Wolff I, et al. Among authors: bruntsch u. Clin Cancer Res. 1996 Oct;2(10):1717-23. Clin Cancer Res. 1996. PMID: 9816122 Clinical Trial.

4

Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486A in phase I studies in patients with advanced cancers.

Zhou H, Choi L, Lau H, Bruntsch U, Vries EE, Eckhardt G, Oosterom AT, Verweij J, Schran H, Barbet N, Linnartz R, Capdeville R. Zhou H, et al. Among authors: bruntsch u. J Clin Pharmacol. 2000 Mar;40(3):275-83. doi: 10.1177/00912700022008946. J Clin Pharmacol. 2000. PMID: 10709156 Clinical Trial.

5

Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group.

Kaplan S, Hanauske AR, Pavlidis N, Bruntsch U, te Velde A, Wanders J, Heinrich B, Verweij J. Kaplan S, et al. Among authors: bruntsch u. Br J Cancer. 1996 Feb;73(3):403-5. doi: 10.1038/bjc.1996.70. Br J Cancer. 1996. PMID: 8562351 Free PMC article. Clinical Trial.

6

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

Catimel G, Vermorken JB, Clavel M, de Mulder P, Judson I, Sessa C, Piccart M, Bruntsch U, Verweij J, Wanders J, et al. Catimel G, et al. Among authors: bruntsch u. Ann Oncol. 1994 Jul;5(6):543-7. doi: 10.1093/oxfordjournals.annonc.a058910. Ann Oncol. 1994. PMID: 7918127 Free article. Clinical Trial.

7

Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicity.

Aamdal S, Bruntsch U, Kerger J, Verweij J, ten Bokkel Huinink W, Wanders J, Rastogi R, Franklin HR, Kaye SB. Aamdal S, et al. Among authors: bruntsch u. Cancer Chemother Pharmacol. 1997;40(5):439-43. doi: 10.1007/s002800050683. Cancer Chemother Pharmacol. 1997. PMID: 9272122 Clinical Trial.

8

Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC Early Clinical Trials Group.

Bruntsch U, Heinrich B, Kaye SB, de Mulder PH, van Oosterom A, Paridaens R, Vermorken JB, Wanders J, Franklin H, Bayssas M, et al. Bruntsch U, et al. Eur J Cancer. 1994;30A(8):1064-7. doi: 10.1016/0959-8049(94)90457-x. Eur J Cancer. 1994. PMID: 7654430 Clinical Trial.

9

Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors.

Punt CJ, Boni J, Bruntsch U, Peters M, Thielert C. Punt CJ, et al. Among authors: bruntsch u. Ann Oncol. 2003 Jun;14(6):931-7. doi: 10.1093/annonc/mdg248. Ann Oncol. 2003. PMID: 12796032 Free article. Clinical Trial.

10

TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group.

Gundersen S, Dombernowsky P, Cavalli F, Bruntsch U, Renard J, Van Glabbeke M, Pinedo H. Gundersen S, et al. Among authors: bruntsch u. Eur J Cancer Clin Oncol. 1989 Jul;25(7):1095-7. doi: 10.1016/0277-5379(89)90394-5. Eur J Cancer Clin Oncol. 1989. PMID: 2759163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters